Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis?
- 31 May 2009
- journal article
- Published by Elsevier BV in Clinical Neurology and Neurosurgery
- Vol. 111 (4), 331-334
- https://doi.org/10.1016/j.clineuro.2008.11.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Diffusion tensor imaging for differentiation of recurrent brain tumor and radiation necrosis after radiotherapy—Three case reportsClinical Neurology and Neurosurgery, 2007
- Treatment options for glioblastomaNeurosurgical Focus, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with TemozolomideClinical Cancer Research, 2004
- In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSIJournal of Magnetic Resonance Imaging, 2002
- Brain TumorsNew England Journal of Medicine, 2001
- In vitro evaluation of temozolomide combined with X-irradiationAnti-Cancer Drugs, 1997
- The long-term side effects of radiation therapy for benign brain tumors in adultsJournal of Neurosurgery, 1990
- Reversible Oedema and Necrosis after Irradiation of the Brain Diagnostic Procedures and Clinical ManifestationsActa Oncologica, 1990